Expression of phb2 in rat brain cortex following traumatic brain injury

International Journal of Molecular Sciences

Volumn 15, Issue 2, 2014, Pages 3299-3318

  Xu, Ting ^a,b   Fan, Xinjuan ^b   Tan, Yuanyuan ^b   Yue, Ying ^b   Chen, Weijie ^b   Gu, Xingxing ^b  

^a THE AFFILIATED HUAIAN NO 1 PEOPLE S HOSPITAL OF NANJING MEDICAL UNIVERSITY   (China)

^b NANTONG UNIVERSITY   (China)

Author keywords

Apoptosis; Astrocyte; Neuron; Prohibitin2; Proliferation; Traumatic brain injury

Indexed keywords

CASPASE 3; CYCLINE; GLIAL FIBRILLARY ACIDIC PROTEIN; NEURON SPECIFIC NUCLEAR PROTEIN; PROHIBITIN; PROHIBITIN2; UNCLASSIFIED DRUG; HYDROGEN PEROXIDE; REPRESSOR PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; ASTROCYTE; BRAIN CORTEX; CELL PROLIFERATION; CELL SURVIVAL; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; IMMUNOFLUORESCENCE TEST; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; MALE; MITOSIS; NONHUMAN; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TRAUMATIC BRAIN INJURY; WESTERN BLOTTING; ANIMAL; BRAIN INJURY; CELL CULTURE; CYTOLOGY; DRUG EFFECTS; METABOLISM; PATHOLOGY; PC12 CELL LINE; TIME;

ANIMALS; APOPTOSIS; ASTROCYTES; BRAIN INJURIES; CELL PROLIFERATION; CELL SURVIVAL; CELLS, CULTURED; CEREBRAL CORTEX; HYDROGEN PEROXIDE; MITOSIS; PC12 CELLS; RATS; REPRESSOR PROTEINS; TIME FACTORS;

EID: 84894239311     PISSN: 16616596     EISSN: 14220067     Source Type: Journal    
DOI: 10.3390/ijms15023299     Document Type: Article

References (47)

1. Harvey, L.A.; Close, J.C. Traumatic brain injury in older adults: Characteristics, causes and consequences. Injury 2012, 43, 1821-1826.
2. Cheng, G.; Fu, L.; Zhang, H.Y.; Wang, Y.M.; Zhang, L.M.; Zhang, J.N. The role of mitochondrial calcium uniporter in neuroprotection in traumatic brain injury. Med. Hypotheses 2013, 80, 115-117.
3. Kumar, A.; Loane, D.J. Neuroinflammation after traumatic brain injury: Opportunities for therapeutic intervention. Brain Behav. Immun. 2012, 26, 1191-1201.
4. McIntosh, T.K.; Smith, D.H.; Meaney, D.F.; Kotapka, M.J.; Gennarelli, T.A.; Graham, D.I. Neuropathological sequelae of traumatic brain injury: Relationship to neurochemical and biomechanical mechanisms. Lab. Invest. 1996, 74, 315-342.
5. Zhang, J.; Jiang, R.; Liu, L.; Watkins, T.; Zhang, F.; Dong, J.F. Traumatic brain injury-associated coagulopathy. J. Neurotrauma 2012, 29, 2597-2605.
6. Ofek, H.; Defrin, R. The characteristics of chronic central pain after traumatic brain injury. Pain 2007, 131, 330-340.
7. Blennow, K.; Hardy, J.; Zetterberg, H. The neuropathology and neurobiology of traumatic brain injury. Neuron 2012, 76, 886-899.
8. Bigler, E.D. Neurobiology and neuropathology underlie the neuropsychological deficits associated with traumatic brain injury. Arch Clin. Neuropsychol. 2003, 18, 595-621.
9. Hart, T.; Brenner, L.; Clark, A.N. Major and minor depression after traumatic brain injury. Arch Phys. Med. Rehabil. 2011, 92, 1211-1219.
10. Laird, M.D.; Vender, J.R.; Dhandapani, K.M. Opposing roles for reactive astrocytes following traumatic brain injury. Neurosignals 2008, 16, 154-164.
11. Keane, R.W.; Kraydieh, S.; Lotocki, G.; Alonso, O.F.; Aldana, P.; Dietrich, W.D. Apoptotic and antiapoptotic mechanisms after traumatic brain injury. J. Cereb. Blood Flow Metab. 2001, 21, 1189-1198.
12. Bye, N.; Carron, S.; Han, X. Neurogenesis and glial proliferation are stimulated following diffuse traumatic brain injury in adult rats. J. Neurosci. Res. 2011, 89, 986-1000.
13. Coates, P.J.; Jamieson, D.J.; Smart, K.; Prescott, A.R.; Hall, P.A. The prohibitin family of mitochondrial proteins regulate replicative lifespan. Curr. Biol. 1997, 7, 607-610.
14. Marta, A.S.; Nektarios, T. Opposing function of mitochondrial prohibitin in aging. Aging 2010, 2, 1004-1011.
15. Back, J.W.; Sanz, M.A.; De, J.L. A structure for the yeast prohibitin complex: Structure prediction and evidence from chemical crosslinking and mass spectrometry. Protein Sci. 2007, 11, 2471-2478.
16. Mishra, S.; Murphy, L.C.; Murphy, L.J. The Prohibitins: Emerging roles in diverse functions. J. Cell Mol. Med. 2006, 10, 353-363.
17. Xu, Z.; Wu, J.; Zha, X. Up-regulation of prohibitin 1 is involved in the proliferation and migration of liver cancer cells. Sci. China Life Sci. 2001, 54, 121-127.
18. Coates, P.J.; Nenutil, R.; McGregor, A. Mammalian prohibitin proteins respond to mitochondrial stress and decrease during cellular senescence. Exper. Cell Res. 2001, 265, 262-273.
19. Marta, A.S.; Nektarios, T. Prohibitin and mitochondrial biology. Trends Endocrinol. Metab. 2009, 20, 394-401.
20. Nijtmans, L.G.; Artal, S.M.; Grivell, L.A.; Coates, P.J. The mitochondrial PHB complex: Roles in mitochondrial respiratory complex assembly, ageing and degenerative disease. Cell. Mol. Life Sci. 2002, 9, 143-155.
21. Wang, S.; Nath, N.; Adlam, M.; Chellappan, S. Prohibitin, a potential tumor suppressor, interacts with RB and regulates E2F function. Oncogene 1999, 18, 3501-3510.
22. Wang, S.; Fusaro, G.; Padmanabhan, J.; Chellappan, S.P. Prohibitin co-localizes with Rb in the nucleus and recruits N-CoR and HDAC1 for transcriptional repression. Oncogene 2002, 21, 8388-8396.
23. Merkwirth, C.; Dargazanli, S.; Tatsuta, T. Prohibitins control cell proliferation and apoptosis by regulating OPA1-dependent cristae morphogenesis in mitochondria. Genes Dev. 2008, 22, 476-488.
24. Frezza, C.; Cipolat, S.; Martins, B.O. OPA1 controls apoptotic cristae remodeling independently from mitochondrial fusion. Cell 2006, 126, 177-189.
25. Duvezin-Caubet, S.; Jagasia, R.; Wagener, J. Proteolytic processing of OPA1 links mitochondrial dysfunction to alterations in mitochondrial morphology. J. Biol. Chem. 2006, 281, 37972-37979.
26. Baricault, L.; Segui, B.; Guegand, L. OPA1 cleavage depends on decreased mitochondrial ATP level and bivalent metals. Exp. Cell Res. 2007, 313, 3800-3808.
27. Sun, L.; Liu, L.; Yang, X.J. Akt binds prohibitin 2 and relieves its repression of MyoD and muscle differentiation. J. Cell Sci. 2004, 117, 3021-3029.
28. Mao, Z.; Bonni, A.; Xia, F.; Nadal-Vicens, M.; Greenberg, M.E. Neuronal activity-dependent cell survival mediated by transcription factor MEF2. Science 1999, 286, 785-790.
29. Kasashima, K.; Ohta, E.; Kagawa, Y.; Endo, H. Mitochondrial functions and estrogen receptor-dependent nuclear translocation of pleiotropic human Prohibitin 2. J. Biol. Chem. 2006, 281, 36401-36410.
30. Takata, H.; Matsunaga, S.; Morimoto, A. PHB2 protects sister-chromatid cohesion in mitosis. Curr. Biol. 2007, 17, 1356-1361.
31. Fusaro, G.; Dasgupta, P.; Rastogi, S.; Joshi, B.; Chellappan, S. Prohibitin induces the transcriptional activity of p53 and is exported from the nucleus upon apoptotic signaling. J. Biol. Chem. 2003, 278, 47853-47861.
32. Suzuki, Y.; Demoliere, C.; Kitamura, D.; Takeshita, H.; Deuschle, U. Watanabe, HAX-1, a novel intracellular protein, localized on mitochondria, directly associates with HS1, a substrate of Src family tyrosine kinases. J. Immunol. 1997, 158, 2736-2744.
33. Cilenti, L.; Soundarapandian, M.M.; Kyriazis, G.A. Regulation of HAX-1 anti-apoptotic protein by Omi/HtrA2 protease during cell death. J. Biol. Chem. 2004, 279, 50295-50230.
34. Smalla, K.H.; Mikhaylova, M.; Sahin, J.; Bernstein, H.G.; Bogerts, B.; Schmitt, A.; van der Schors, R.; Smit, A.B.; Li, K.W.; Gundelfinger, E.D.; et al. A comparison of the synaptic proteome in human chronic schizophrenia and rat ketamine psychosis suggest that prohibitin is involved in the synaptic pathology of schizophrenia. Mol. Psychiatry 2008, 13, 876-896.
35. Bernstein, H.G.; Smalla, K.H.; Dürrschmidt, D.; Keilhoff, G.; Dobrowolny, H.; Steiner, J.; Schmitt, A. Increased density of prohibitin-immunoreactive oligodendrocytes in the dorsolateral prefrontal white matter of subjects with schizophrenia suggests extraneuronal roles for the protein in the disease. Neuromol. Med. 2012, 14, 270-280.
36. Shangxun, L.; Bowei, W.; Dan, L. Traumatic brain injury animal model. J. Forensic Med. 2011, 27, 286-289.
37. Swanson, R.A. Astrocyte glutamate uptake during chemical hypoxia in vitro. Neurosci. Lett. 1992, 147,143-146.
38. Takuma, K.; Baba, A.; Matsuda, T. Astrocyte apoptosis: Implications for-neuroprotection. Prog. Neurobiol. 2004, 72, 111-127.
39. Lee, M.Y.; Ju, W.K.; Cha, J.H.; Son, B.C.; Chun, M.H.; Kang, J.K.; Park, C.K. Expression of vascular endothelial growth factor mRNA following transient forebrain ischemia in rats. Neurosci. Lett. 1999, 265, 107-110.
40. Ridet, J.L.; Malhotra, S.K.; Privat, A.; Gage, F.H. Reactive astrocytes: Cellular and molecular cues to biological function. Trends Neurosci. 1997, 20, 570-577.
41. Chowdhury, I.; Thompson, W.E.; Welch, C.; Thomas, K.; Matthews, R. Prohibitin (PHB) inhibits apoptosis in rat granulosa cells (GCs) through the extracellular signal-regulated kinase 1/2 (ERK1/2) and the Bcl family of proteins. Apoptosis 2013, 18, 1513-1525.
42. Fahrig, T.; Gerlach, I.; Horvath, E. A synthetic derivative of the natural product rocaglaol is a potent inhibitor of cytokine-mediated signaling and shows neuroprotective activity in vitro and in animal models of Parkinson's disease and traumatic brain injury. Mol. Pharmacol. 2005, 67, 1544-1555.
43. Basmadjian, C.; Thuaud, F.; Ribeiro, N.; Désaubry, L. Flavaglines: Potent anticancer drugs that target prohibitins and the helicase eIF4A. Future Med. Chem. 2013, 5, 2185-2197.
44. Ribeiro, N.; Thuaud, F.; Nebigil, C.; Désaubry, L. Recent advances in the biology and chemistry of the flavaglines. Bioorg. Med. Chem. 2012, 20, 1857-1864.
45. Feeney, D.M.; Boyeson, M.G.; Linn, R.T.; Murray, H.M.; Dail, W.G. Responses to cortical injury: I Methodology and local effects of contusions in the rat. Brain Res. 1981, 211, 67-77.
46. Golarai, G.; Greenwood, A.C.; Feeney, D.M.; Connor, J.A. Physiological and structural evidence for hippocampal involvement in persistent seizure susceptibility after traumatic brain injury. J. Neurosci. 2001, 21, 8523-8537.
47. McCarthy, K.D.; de Vellis, J. Preparation of separate astroglial and oligodendroglial cell cultures from rat cerebral tissue. J. Cell. Biol. 1980, 85, 890-902.